NCT02028013

Brief Summary

Bioresonance is the big promise of the medical technology of the future because it stimulates the self-regenerating system of the body by affecting the body's most essential procedures. The big advantage is that its multiple and there are no harmful side effects. This therapy teaches something to the body what in a younger and healthier state it had already Bioresonance is based on the scientific principle that metabolism within cells is influenced by one's electromagnetic field. We start to use bioresonance technology in management of erectile dysfunction , premature ejaculation, decreased libido.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 3, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 6, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

April 8, 2015

Status Verified

April 1, 2015

Enrollment Period

3.5 years

First QC Date

January 3, 2014

Last Update Submit

April 7, 2015

Conditions

Sexual DysfunctionErectile DysfunctionPremature Ejaculation

Keywords

Erectile dysfunction, sexual dysfunction, bioresonance

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction

    2-6 months

Secondary Outcomes (1)

  • Penile duplex study

    2 months

Eligibility Criteria

Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients complaining from erectile dysfunction

You may qualify if:

  • erectile dysfunction Premature ejaculation Decreased libido

You may not qualify if:

  • nil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Man Clinic

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Sexual Dysfunction, PhysiologicalErectile DysfunctionPremature Ejaculation

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesGenital Diseases, MaleMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental DisordersEjaculatory Dysfunction

Study Officials

  • Khaled A Gadalla, MD

    AlAzhar university , Man clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Khaled A Gadalla, MD, ABS

CONTACT

20222725025Khaledgadalla@gmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

January 3, 2014

First Posted

January 6, 2014

Study Start

January 1, 2013

Primary Completion

July 1, 2016

Study Completion

August 1, 2016

Last Updated

April 8, 2015

Record last verified: 2015-04

Locations

EG(1)